Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters
Marcin Pasiarski,1,2 Barbara Sosnowska-Pasiarska,3 Ewelina Grywalska,4,5 Agnieszka Stelmach-Gołdyś,1 Artur Kowalik,6 Stanisław Góźdź,2,7 Jacek Roliński4,5 1Department of Hematology, Holycross Cancer Center, Kielce, Poland; 2Department of Immunology, Faculty of Health Sciences, Jan Kochano...
Enregistré dans:
Auteurs principaux: | Pasiarski M, Sosnowska-Pasiarska B, Grywalska E, Stelmach-Gołdyś A, Kowalik A, Góźdź S, Roliński J |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5e1337339c0d41e883e1e6f39955b0ea |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Patologías cutáneas asociadas a gammapatías monoclonales: ¿qué sabemos hasta ahora?
par: Meza-Romero,Rodrigo, et autres
Publié: (2021) -
Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
par: Omar M. Ismail, et autres
Publié: (2021) -
Renal confined sarcoidosis: Natural history and diagnostic challenge
par: Azam Ghafoor, et autres
Publié: (2014) -
The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities
par: Yan Li, et autres
Publié: (2021) -
Neumonía neumocócica bacteriémica en adultos en hospital regional de Chile
par: Rioseco Z.,María Luisa, et autres
Publié: (2018)